For autoimmune patients already at risk for bone loss, this could be a clinically meaningful distinction when choosing between available GLP-1/GIP medications
The takeaway isnt that these medications should be avoided, but rather that being aware of potential cutaneous effects can help clinicians recognize medication-related skin changes quicker and manage them appropriately. For more information: Marisa Fat, BS , can be reached at [email protected].
Headaches Akhil Shenoy, M.D., states that 15% of Ozempic users experience headaches based on existing studies (23)
Serving overseas at the end of the war, he was running the RAF Air Mail service to Cologne
Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME, Hollenberg AN, Baggio L, Saper CB, Drucker DJ, et al: Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons